[HTML][HTML] Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths …

JA Kim, S Yoon, LY Kim, DS Kim - Journal of Korean medical …, 2017 - ncbi.nlm.nih.gov
Abstract Health Insurance and Review Assessment (HIRA) in South Korea, also called
National Health Insurance (NHI) data, is a repository of claims data collected in the process …

[HTML][HTML] Tuberculosis and chronic respiratory disease: a systematic review

AL Byrne, BJ Marais, CD Mitnick, L Lecca… - International Journal of …, 2015 - Elsevier
Background Chronic respiratory disease causes substantial global morbidity and mortality.
The contribution of pulmonary tuberculosis to the aetiology of chronic respiratory disease is …

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

IS Pradipta, LD Forsman, J Bruchfeld, E Hak… - Journal of Infection, 2018 - Elsevier
Objectives Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the
setting, we aimed to determine the associations of risk factors of MDR-TB across different …

Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD

M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

D Price, D West, G Brusselle… - … journal of chronic …, 2014 - Taylor & Francis
Background Despite the availability of national and international guidelines, evidence
suggests that chronic obstructive pulmonary disease (COPD) treatment is not always …

[HTML][HTML] Corticosteroids for COVID-19 therapy: potential implications on tuberculosis

R Gopalaswamy, S Subbian - International journal of molecular sciences, 2021 - mdpi.com
On 11 March 2020, the World Health Organization announced the Corona Virus Disease-
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …

The risk of mycobacterial infections associated with inhaled corticosteroid use

SK Brode, MA Campitelli, JC Kwong… - European …, 2017 - Eur Respiratory Soc
Inhaled corticosteroid (ICS) use is associated with an increased risk of pneumonia. This
study was performed to determine if ICS use is associated with an increased risk of …

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

N Zhong, C Wang, X Zhou, N Zhang… - … journal of chronic …, 2015 - Taylor & Francis
Background The current Global initiative for chronic Obstructive Lung Disease (GOLD)
treatment strategy recommends the use of one or more bronchodilators according to the …

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

G Brusselle, D Price, K Gruffydd-Jones… - … journal of chronic …, 2015 - Taylor & Francis
Background Real-world prescription pathways leading to triple therapy (TT)(inhaled
corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting …

[HTML][HTML] Does tuberculosis threaten our ageing populations?

R Byng-Maddick, M Noursadeghi - BMC infectious diseases, 2016 - Springer
Background The global population is ageing quickly and our understanding of age-related
changes in the immune system suggest that the elderly will have less immunological …